Strict blood sugar control in some diabetics does not lower heart attack, stroke risk

Last Updated on Friday, 18 December 2009 01:33 Written by Natural Health Team Friday, 18 December 2009 01:33

Enzyme may create new approach to hypertension therapy
( Northwestern University ) New research from Northwestern University has found that an alternative therapy may be possible for treating some types of hypertension using an enzyme called ACE2.
Enzyme may create new approach to hypertension therapy
New research from the Northwestern University Feinberg School of Medicine has found that an alternative therapy may be possible for treating some types of hypertension using an enzyme called ACE2.
Population Attributable Risk of Incident Hypertension in Women [Letters]
To the Editor: The objective of the cohort study by Dr Forman and colleagues 1 was to estimate the hypothetical fraction of hypertension incidence associated with dietary and lifestyle factors in women.
Second Pivotal Phase III Study Of Gilead’s Darusentan For Resistant Hypertension Misses Primary Endpoints
Gilead Sciences, Inc. (Nasdaq:GILD) announced that DAR-312 (DORADO-AC), a Phase III clinical trial evaluating darusentan, the company’s endothelin receptor antagonist (ERA) for the treatment of resistant hypertension, did not achieve its co-primary efficacy endpoints of change from baseline to week 14 in trough sitting systolic blood pressure (SBP) and diastolic blood pressure (DBP) compared to …
Strict blood sugar control in some diabetics does not lower heart attack, stroke risk
Strictly controlling blood glucose levels in type 2 diabetics with long-term, serious coexisting health problems such as heart disease and hypertension does not lower their risk of a heart attack or stroke, according to a new study.

« My Chemical Romance- Cancer Lyrics | Understanding Cholesterol (Cholesterol #1) »